Adialante Seed Round Target
Adialante plans to close a seed round with a target of $15–20 million.
Adialante develops affordable, silent, and compact MRI systems to meet global demands.
No allocation disclosed
This holding has no reported allocation yet. It will appear here once a filing discloses one.
Adialante plans to close a seed round with a target of $15–20 million.
Adialante has received $19.5 million in letters of intent and has 11 clinics signed up.
Adialante now has an office space in the Bay Area, and Efrain Torres plans to permanently move the startup to the West Coast.
Adialante received a $500,000 investment as part of joining Y Combinator's accelerator program.
Adialante participated in Y Combinator's Spring 2026 batch.
Efrain Torres traveled to Silicon Valley to participate in Y Combinator's three-month mentorship program for early-stage companies.
Accepted into Y Combinator's Spring 2026 (P26) batch
Adialante participated in Y Combinator's accelerator program in spring 2026.
Adialante is accepted into Y Combinator's P26 cohort.
Adialante's whole-body MRI scanner is fully operational as of this year, assembled for less than $1 million.
The federal government awarded Adialante $2 million in Small Business Innovation Research funding, which was later paused for nine months.
Adialante was accepted into Y Combinator's Spring 2026 batch.